Razadyne IR Side Effects
Please note - some side effects for Razadyne IR may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects by Body System - for Healthcare Professionals
Applies to: oral capsule, extended release; oral solution; oral tablet
Gastrointestinal side effects including nausea (24%), vomiting (13%), diarrhea (9%), abdominal pain (5%), and dyspepsia (5%) have been reported. Gastrointestinal side effects reported postmarketing have included upper and lower GI bleeding, stomach discomfort, and abdominal discomfort.
General side effects including weight decrease (7%), fatigue (5%), and syncope (2%) have been reported. Chest pain, asthenia, fever, and malaise have been reported frequently.
In two randomized, placebo-controlled trials of two years duration in subjects with mild cognitive impairment, a total of 13 subjects on galantamine (n=1026) and 1 subject on placebo (n=1022) died. The deaths were due to various causes which could be expected in an elderly population. About half of the galantamine deaths appeared to result from various vascular causes (myocardial infarction, stroke), and sudden death.
Nervous system side effects including dizziness (9%), headache (8%), and tremor (3%) have been reported. Leg cramps, tinnitus, transient ischemic attacks and cerebrovascular accidents have been reported infrequently. Nervous system side effects reported postmarketing have included lethargy, dysgeusia, and hypersomnia.
Psychiatric side effects including anorexia (9%), depression (7%), insomnia (5%), and somnolence (4%) have been reported. Apathy, paroniria (disagreeable or terrifying dreams), paranoid reaction, increased libido, and delirium have been reported infrequently. Suicidal ideation and suicide have been reported rarely.
Genitourinary side effects including urinary tract infection (8%) and hematuria (3%) have been reported.
Respiratory side effects including rhinitis (4%) have been reported.
Hematologic side effects including anemia (3%) have been reported.
Cardiovascular side effects including bradycardia (up to 3%) have been reported. Postural hypotension, hypotension, dependent edema, cardiac failure, and myocardial ischemia or infarction, AV block, palpitation, atrial arrhythmias including atrial fibrillation and supraventricular tachycardia, QT prolonged, bundle branch block, T-wave inversion, and ventricular tachycardia have been reported infrequently. Severe bradycardia has rarely been reported.
Ocular side effects reported postmarketing have included blurred vision.
Hepatic side effects reported postmarketing have included elevated liver enzymes and hepatitis.Top
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.